This is a positive development, not a complication, and it means your team should schedule TSH rechecks every 68 weeks during active weight loss
The treatment option with the combination of a DPP-4 inhibitor as add on to metformin is currently the most widely used
Specific benefits for people with high blood pressure include: Weight reduction : Weight loss varies by agent and dosemore substantial with higher doses of semaglutide (Wegovy) for obesity management, and more modest with standard diabetes doses of GLP-1 agonists Reduced arterial stiffness : Some studies suggest GLP-1 agonists may improve vascular function Kidney effects : Some GLP-1 agonists have shown benefits in reducing albuminuria and slowing kidney disease progression, though SGLT2 inhibitors are generally preferred for kidney protection in diabetes [10] [19] Reduced cardiovascular events : The overall reduction in heart attacks and strokes benefits people with hypertension However, it is important to understand the potential risks and side effects
The interaction between GLP-1, IELs and gut microbiota highlights its vital role in preserving the integrity of the intestinal mucosal barrier and the gut immunity homeostasis
Non-MS-based CE : For cases where MS is not available, CE alone can provide valuable information on the relative distribution of acylcarnitines by comparing migration times and peak intensities, although this approach lacks the sensitivity and specificity of MS
